CHF Flashcards

1
Q

1 cause of left heart failure and right heart failure

A

L: MI
R: PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 3 determinants of stroke volume

A
  1. preload
  2. afterload
  3. myocardial contractility

CO=SV x HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The amount of myocardial stretch at the end of diastole

A

Preload

*The more a normal ventricle is distended (filled with blood) during diastole, the greater the volume of blood ejected during the next systolic contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The resistance a heart must overcome to empty it’s content

A

afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ventricular wall stress increases in response to

A
  1. the arterial systolic pressure (i.e. hypertension)

2. Increased chamber size (e.g. dilated heart chamber)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

___ serves an initial compensatory role in reducing wall stress

A

An increase in wall thickness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

changes in the force generated by the myocardium for a given set of preload and afterload conditions

A

contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

3 causes of heart failure

A

(decreased Cardiac Output)

  1. Impaired ventricular filling (Decrease in Preload)
  2. Increased Afterload
  3. Impaired Contractility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What happens to preload, afterload, and contractility as SV increases

A
  1. Increase in preload
  2. Decrease in afterload
  3. Increased contractility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What type of heart failure is more common

A

systolic (2/3)- Ventricles become enlarged, and pump out less than 40-50% of blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cause of diastolic dysfunction and systolic dysfunction

A

Diastolic: Decreased filling
Ventricles stiff/cannot relax
Normal left ventricular ejection fraction (> 50%)
-CO limited during exertion (cannot take in larger volume in ventricle)

Systolic: Cause: Impaired Contractility or excessive afterload
Ventricles thinned, stretched, enlarged
Decreased LVEF (<40-50%)
-decreased output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Causes of Left sided HF

A
  1. MI (#1 cause)
  2. Aortic stenosis
  3. uncontrolled HTN
  4. Mitral stenosis
  5. percaridal tamponade
  6. LVH
  7. dilated cardiomyopathy

(change this card)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

__ Ventricle is thinner / highly compliant as it ejects against a low pulmonary vascular resistance.

A

Right

*Very susceptible with sudden increases in afterload (e.g. PE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

isolated right heart failure is care (called __)

A

cor pulmonale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Most common cause of right heart failure is

A

left heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Presentation of left sided heart failure

A
  1. Dyspnea,
  2. Orthopnea,
  3. Paroxysmal Nocturnal Dyspnea,
  4. Nocturnal Cough

*Back up comes from lungs therefore lung sx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Presentation of right sided heart failure

A
  1. Peripheral Edema,
  2. RUQ Discomfort / hepatic enlargement

*Back up comes from body therefore sx in body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the cycle of chronic HF

A
  1. increased BP/CO
  2. increased cardiac workload
  3. LV dysfunction
  4. Decreased CO/BP
  5. hemodynamic remodeling, neurohormonal activation
  6. increased HR, contractility, vasoconstriction, increased volume
    * cycle continues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Compensatory mechanism of HF

A
  1. ALL in response to decreased BP (BP = CO x TPR)
  2. Neurohormonal mechanisms (increase TPR)
  3. Autocrine System of Myocytes (Natriuretic Peptides)
  4. Ventricular Hypertrophy and Remodeling

*These are targets for treatment!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Neurohormonal mechanisms (increase TPR)

A
  1. Sympathetic Nervous System (Adrenergic mechanisms)
  2. RAA system
  3. Increased ADH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How does the sympathetic nervous system compensate in HF

A
  1. Decreased CO = Decreased Perfusion pressure to baroreceptors in the heart (low BP)
  2. Sympathetic and Adrenal Epi / Norepi outflow to the heart and peripheral circulation is increased
    -Increased CO: Increased heart rate (B-adrenergic stim.)
    contractility
    -Increased TPR: Vasoconstriction 2/2 alpha receptors

*Excess norepinephrine “toxic” to myocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Excess ___ “toxic” to myocyte

A

norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

RAA/ADH system response to HF and its effects

A
  1. Decreased CO = Decreased Perfusion pressure to juxtaglomerular cells / macula densa of the kidney
  2. Increased Renin Release
  3. Increased ADH (Vasopressin)

EFFECTS: cardiac hypertrophy, vasoconstriction, increase BV, fluid/Na retention,)

24
Q

___ Lends support to a suspected diagnosis of HF but should not be used in isolation to confirm or exclude the presence of HF.

A

Elevated BNP

25
Q

ANP/BNP produced and stored by __. Released in response to ___, __, and ___stimulation

A

myocytes

atrial/ventricular distension (stretch), Angiotensin II and NE

26
Q

Elevated BNP is associated with

A
  1. hypervolemic states (e.g. HF)
  2. reduced LVEF
  3. LVH
  4. elevated LV filling
  5. AMI
  6. PE
  7. COPD
27
Q

BNP have a __ and ___ effect

A

Natriuretic and vasodilatory effect

28
Q

____ stimulates the development of myocardial hypertrophy and deposition of extracellular matrix which maintains contractile force

A

A sustained increase in wall stress

29
Q

Comes at the expense of higher Diastolic ventricular pressures which are transmitted to the left atria and pulmonary vasculature

A

LVH and remodeling

30
Q

CHF patients present in 1 of 3 ways:

A
  1. Decreased Exercise Tolerance (Fatigue)
  2. Syndrome of Fluid Retention
  3. NO symptoms- (i.e. incidental discovery found to have cardiac enlargement or dysfunction)
31
Q

PE findings of right sided HF

A
  1. JVD
  2. Hepatomegaly
  3. Peripheral Edema
32
Q

PE findings of left sided HF

A
1. Tachycardia, 
2,Tachypnea, dyspnea, 
3. orthopnea, PND
4. Pulmonary Rales (Crackles) = Fluid at the Alveolar Level
5. Pneumonia or CHF
S3 Gallop
33
Q

Echo (the main tool of HF) ask 3 basic questions

A
  1. Is the LVEF preserved or reduced? (55-75%)
  2. Is the structure of the LV normal or abnormal? (Size, Wall Thickness, and Motion)
  3. Are there other structural abnormalities (such as valvular, Pericardial, Or right ventricular abnormalities) that could explain the clinical presentation?
  • Baseline for comparison
  • Severity of structural remodeling
  • Repeat assessment of LVEF may be helpful with a major change in clinical status.
34
Q

EKG changes with heart failure

A
  1. LBBB
  2. LVH
  3. Afib w/ RVR (140)

*look for evidence of prior MI, LVH, cardiac conduction abnormality or cardiac arrhythmia

35
Q

Labs to check with heart failure

A
  1. Electrolytes
  2. Renal Function
  3. CBC
  4. UA
  5. A1C
  6. Lipid Panel
  7. Hepatic Function
  8. Thyroid Function
  9. Transferretin
  10. HIV
  11. BNP

*Don’t get all of these all the time be get what is applicable for DDX

36
Q

Imaging for CHF

A
  1. Echo
  2. EKG
  3. CXR
  4. +/- cardiac cath if angina suspected
37
Q

CXR changes with HF

A
  1. What are you looking for:
    the degree of cardiac enlargement and pulmonary congestion or to detect the presence of pulmonary disease
  2. cardiomegaly with diffuse pulmonary infiltrate consistent with pulmonary edema.
38
Q

Risk factors for heart failure

A

(all can cause remodelling)

  1. HTN
  2. Valvular Heart Disease
  3. Diabetes
  4. Myocardial infarction
  5. Atherosclerosis
  6. Cardiomyopathy
  7. Arrhythmias and LBBB
  8. COPD
  9. Cardiotoxic drugs (smoking, alcohol, cocaine, ephedra, NSAIDs)
39
Q

Three Classes of drugs can exacerbate the syndrome of HF and should be avoided:

A
  1. Antiarrhythmic agents
  2. CCB’s (vasodilation and worsening edema)
  3. NSAID’s (Na retention, peripheral vasoconstriction)
40
Q

Pharmacologic therapy for stage A/B heart failure

A
  1. ACEI/ARB (inhibit remodeling)**

2. BBs

41
Q

Describe the use of BB for HF

A
  1. Counters effect of SNS
  2. Must if post MI (inhibits remodeling)
  3. Atenolol / Metoprolol (Beta-1 selective)
  4. Carvedilol (non-selective, but can decrease remodeling) and Labetolol (potent Vasodilator) Can Exacerbate HF
  5. Start Low, Go Slow to prevent CHF sx
42
Q

When do you get an Echo for CHF

A

change of symptoms or exacerbation

43
Q

Describe the stages of HF

A

A: at high risk for HF but w/o structural heart dz or sx of HF

B: structural heart disease but w/o signs or sx of HF

C: structural heart dz w/ prior or current sx of HF

D: refractory HF requiring specialized interventions

44
Q

What stage of HF?

pts w/ known structural heart dz and SOB and fatigue, reduced exercise tolerance

A

C

45
Q

What stage of HF?

Pts w/ HTN, atherosclerotic dz, DM, obesity, metaboilc sydnrome or using cardiotoxins w/ FHx CM

A

A

46
Q

What stage of HF?

pts w/ previous MI, LV remodeling including LVH and low EF, asymptomatic valve dz

A

B

47
Q

What stage of HF?
pt who have marked sx at rest despite maximal therapy (those who are recurrently hospitalized or cannot be safely discharged from hospital w/o specialized intervention

A

D

48
Q

Goals of Stage A HF tx

A
  1. tx HTN,
  2. smoking sessation,
  3. lipids,
  4. exercise,
  5. discourage alcohol and ilicit drug use
  6. control metabolic syndrome
49
Q

Goals of Stage B HF

A
  1. all measures under stage A
50
Q

Goals of Stage C HF

A
  1. all measures under stage A and B

2. dietary salt restriction

51
Q

Pharmacologic therapy for Stage C/D

A
  1. ACEI/ ARBs
  2. BB
  3. Diuretics (HCTZ, aldosterone blockers- spironolactone)
  4. +/- digoxin

*You should really have specialty support at these stages

52
Q

pharmacological effects of digoxin

A
  1. positive inotropic effect (use in Afib)

2. neurohormonal effects (dec. renin and NE at low doses)

53
Q

When do refer with CHF

A
  1. Stage C
  2. Conduction abnormality
  3. Suspect prior/unknown MI
  4. Suspect CAD
  5. Evidence of PHTN
54
Q

Non-pharmacologic therapies of HF

A
  1. Implantable Cardioverter / Defibrillator
    - Non ischemic cardiomyopathy
    - LVEF <35%
  2. Tx of arrhythimas (QRS over 0.12s)/ cardiac resynchronization
  3. revascularization for ischemia
  4. acute pulmonary edema tx
    - LMNOP (Lasix, Morphine, Nitrates (pressors), Oxygen, Position)
55
Q

Home monitoring of HF goals

A

Preventing Acute exacerbations / Hospitalizations and Improving QUALITY of life

56
Q

Home monitoring of HF includes educating about

A
  1. Recognition of warning signs of worsening function
  2. Weight should be monitored daily
  3. Understanding of Med Regimens
  4. Diet Adjustment- Salt / sodium Restriction (less than 2000mg QD)
  5. Promote Moderate Physical Activity if tolerated
  6. Infections: Pneumo Vax / Influenza Vaccination

*teach pts and family members

57
Q

Early treatment in HF is important because

A

slow progression or reverse staging

  • HF is progressive and dynamic
  • Mortality rates not changing but quality of life can be improved